In a sterilization process where biological indicator (BI) sterility results are used as part of product release criteria, the BIs shall be procured from an approved supplier with a minimum population of test organisms defined. The population of the test organisms upon receipt at the test facility should be verified per ISO 11138-1 Sterilization of health care products – Biological indicators – Part 1: General requirements.
In ethylene oxide and dry heat sterilization, the test organism used is typically the endospore-forming bacteria, Bacillus atrophaeus, (ISO11138-2 Sterilization of health care products – Biological indicators – Part 2: Biological indicators for ethylene oxide sterilization processes and ISO11138-4 Biological indicators – Part 4: Biological indicators for dry heat sterilization processes) with each unit having a minimum population of 1 x 10 6.
This spore population should be verified prior to use for routine sterilization purposes, to ensure that:
- The spore population is as stated by the manufacturer on the certificate of analysis (COA)
- The transit and storage conditions have not affected the spore population
Moist heat and vaporized hydrogen peroxide (VHP) modalities typically use a thermophilic endospore-forming bacteria, Geobacillus stearothermophilus.
Manufacturers are required by ISO 11138-1 to provide the name of the test organism; instructions for use, storage, testing, and disposal; and the nominal population and resistance information with each biological indicator batch.
How to the Population Verification is Performed
To verify the spore population of the test organism, samples of biological indicators are selected from each distinct manufacturer batch per delivery received. ISO 11138-1 defines the minimum sample number of four biological indicators for population verification.
Biological indicators are assayed following manufacturer’s instruction, usually involving extraction, and sometimes requiring maceration of a paper strip, heat-shocking, serial dilution, pour-plating, incubation, and enumeration. Manufacturer and biological indicator product methods may vary in extraction techniques, as well as heat-shocking and incubation temperatures of different test organisms, and appropriateness should be verified by end-user performing the test.
Following the incubation period, the colony forming units (CFUs) are enumerated and the results recorded.
Results are then compared to the manufacturer’s certificate nominal population. Verification of the population is achieved if the test result is between 50% and 300% of the nominal certificate population.
Per Section 6.3.2 of ISO 11138-2, if the end-user population verification performed during the manufacturer’s stated shelf-life results in a population below 1×10 6 but still falls between 50% to 300% criteria, the verification is acceptable.
Screening for Adverse and Inhibitory Substances
Test method validation for adverse and/or inhibitory substances is important to ensure that the measurement of contamination on a device is not impacted by substances present in the test. Adverse substances and/or inhibitory substances (e.g. antimicrob
What is Bioburden Recovery Efficiency and How to Approach Lower Than Desired Recovery Results
What is Recovery Efficiency (RE)? Recovery Efficiency (RE) is an important part of the validation of the bioburden test method. It is intended to provide an assessment of the efficiency of the extraction technique to remove viable microorganisms from a
The Basics of Bioburden Testing
What is bioburden? Bioburden is the quantity and types of native bacterial and fungal flora present on or in a device, substrate, or chemical (test unit). Bioburden plays a large role in determining what is necessary to achieve sterility, and can impac
Custom laboratory and in-line test equipment.
We build a wide range of laboratory and in-line test equipment to suit our customers’ exact needs.